Current and Future Nuclear Theranostic Approaches
| Nuclear theranostic pair | Target | Application |
| 68Ga- and 177Lu-DOTATATE | Somatostatin receptors | NETs |
| 68Ga- and 177Lu-PSMA | PSMA | Prostate cancer |
| 123I- and 131I-iobenguane | Norepinephrine reuptake transporter | Neuroblastoma, paraganglioma, pheochromocytoma |
| 68Ga- and 177Lu-FAPI | Fibroblast activation protein | Multiple cancers |
| 68Ga- and 177Lu-3BP-227 NTR1 antagonist | Neurotensin receptor 1 | Pancreatic cancer |
| 124I- and 131I-girentuximab | Carbonic anhydrase 9 | Renal cell cancer |
| 123I- and 131I-iodine | Sodium/iodide symporter | Thyroid diseases |
FAPi = fibroblast activation protein inhibitor.